For Scientific Institutions, Racial Reconciliation Requires Reparations
By C. Brandon Ogbunu,
Scientific American
| 06. 12. 2020
Antiracism in science must be about much more than challenging the bigoted graybeards of our past such as Ronald A. Fisher.
Ronald Fisher as a steward at the First International Eugenics Conference, 1912 (via wikipedia)
Amidst protests and conversations on racism following several instances of police violence, scientific institutions are reevaluating their approach to dealing with anti-Black racism—extant, historical or symbolic. For example, on Wednesday, June 10, a large segment of the scientific community (and the staffs of prominent journals) participated in a strike, where the goal was to reflect on how Black people—students, trainees, staff, and faculty—are treated, and how we can make the scientific paradigm more inclusive.
This includes several ongoing policy discussions surrounding diversity and inclusion, and very specific exchanges about how we remember and celebrate historical figures. For example, the Society for the Study of Evolution (SSE) is one of many influential scientific societies embroiled in a debate over renaming a prestigious award that currently commemorates Ronald A. Fisher (the R.A. Fisher Prize). Fisher was a pioneer of modern population genetics and one of the most influential scientists of the last century. His influence is as great in genetics as it is statistics, the latter...
Related Articles
By Emily Baumgaertner Nunn, The New York Times | 09.08.2026
It is one of biology’s most ingenious rhythms: Every baby is born young. No matter how much wear and tear their parents’ DNA accumulated over their lifetimes, reproduction erases the molecular scars, handing a clean slate to the next generation...
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Jessica Hamzelou, MIT Technology Review | 07.30.2026
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to...
By Jessica Hamzelou, MIT Technology Review | 07.23.2026
When it comes to organ donation, time is everything. As soon as an organ has been carefully removed from a donor’s body, it starts to deteriorate. Surgeons have a matter of hours to get it into a recipient. Leave...